PerkinElmer’s DELFIA Xpress PIGF 1-2-3 assay has been successfully utilized for identifying and monitoring women who are at risk of preeclampsia as part of Fetal Medicine Foundation’s ASPRE study.
Recent Media Coverage
Read recent articles about PerkinElmer below. Clicking a headline will take you to the publication’s website for the full article.
China is making progress in its fight against pollution, though it still has a long way to go.
The deal will expand PerkinElmer's reach into autoimmune and allergy diagnostic markets.
PerkinElmer’s TR-FRET-based homogeneous assays use metal chelates as donor fluorophore.
PerkinElmer's Torion T-9 portable GC/MS brings new meaning to portability.
A new immunoassay developed by PerkinElmer has been demonstrated to successfully screen for Duchenne muscular dystrophy (DMD) – a fatal X-chromosome recessive disorder, affecting 1 in 5000 male births world-wide.
ViaCord helped fund a small, but promising study that suggests stem cells from a child’s own cord blood may offer an effective treatment for autism symptoms.
The endothelial cells that line our blood vessels play an important role in maintaining and regulating blood flow, contributing to the natural process called haemostasis. PerkinElmer Opera Phenix™ system highlighted.